Table 5.

Use of Anti-Methicillin-Resistant Staphylococcus aureus Antibiotics (Vancomycin or Linezolid) Within 3 Days of Hospital Presentation, by Etiology Group

Etiology Group	Patients, n	Anti-MRSA Antibiotics, n (row %)
All community-acquired pneumonia	2259	674 (29.8)
Staphylococcus aureus	37	34 (91.9)
MRSA	15	14 (93.3)
MSSA	22	20 (90.9)
All-cause non-Staphylococcus aureus	2222	640 (28.8)
Pneumococcal	115	54 (47.0)

Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.